Pirfenidone Capsules

DRUG2 trials

Sponsors

Beijing Continent Pharmaceutical Co, Ltd., Shanghai Zhongshan Hospital

Conditions

PneumoconiosisTakayasu Arteritis

Phase 3

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

RecruitingNCT05288179

Beijing Continent Pharmaceutical Co, Ltd.Pneumoconiosis

Start: 2022-06-07End: 2026-09-30Target: 272Updated: 2025-11-24

Phase 4

Effect of Pirfenidone on TA Fibrosis

Not yet recruitingNCT07325357

Shanghai Zhongshan HospitalTakayasu Arteritis

Start: 2025-12-20End: 2030-12-31Target: 92Updated: 2026-01-08